October 31, 2026

Capitalizations Index – B ∞/21M

Winklevoss Twins Secure Patent for Cryptocurrency ETP Exchange

Winklevoss twins secure patent for cryptocurrency etp exchange

Winklevoss Twins Secure Patent for Cryptocurrency ETP Exchange

Winklevoss twins bitcoin
Advertisement

Join our community of 10 000 traders on Hacked.com for just $39 per month.

According to a patent filing made public by the United States Patent and Trademark Office on May 8, 2017, Cameron and Tyler Winklevoss have won a patent for settling exchange-traded products (ETPs) with digital currencies, including bitcoin, ripple, dogecoin and ethereum.

ETPs are derivative-based investments that are traded on a securities exchange. An ETP is generally valued on the basis of a benchmark stock or commodity, which in the case of Winklevoss IP’s patent would be bitcoin or some other cryptocurrency. While derivative-based cryptocurrency investments already exist in the form of the bitcoin futures contract offered by CBOE and CME Group, no ETPs exist for the US cryptocurrency market yet.

The document reveals that the Winklevoss Twins first applied for the patent in December 2017 through their jointly-owned venture, Winklevoss IP.

The Winklevoss Twins are rather popular personalities in the digital currency community and are among the richest crypto holders worldwide, thanks to their multi-million dollar investment in bitcoin and related companies several years ago. In 2015, they founded the cryptocurrency exchange Gemini, that went on to become the “world’s first licensed ethereum exchange” in 2016.

Wall street
The Winklevoss twins have thus far failed to secure SEC approval for a much-anticipated bitcoin ETF.

The patent application is yet another attempt by the twins at bagging a cryptocurrency-based exchange traded product, with the first ETF proposal being turned down by the United States Securities and Exchange Commission back in March 2017.

Explaining the move, the SEC disclosed,

“The Commission is disapproving this proposed rule change because it does not find the proposal to be consistent with Section 6(b)(5) of the Exchange Act, which requires, among other things, that the rules of a national securities exchange be designed to prevent fraudulent and manipulative acts and practices and to protect investors and the public interest.”

Now that major investment companies, including Goldman Sachs, are rumored to bring bitcoin trading to Wall Street though, it is possible that the SEC will warm to the volatile asset class as it continues to mature. However, any attempt to introduce an ETF by the Winklevoss Twins will still have to be approved by the commission. So far, no company has managed to secure the right to offer a cryptocurrency-based ETF to investors.

Winklevoss IP, the company that was awarded the patent, has managed to secure five patents in the five months since the start of 2018. The previous patent, disclosed in mid April, aimed to improve security in cryptocurrency transactions using a number of common cryptographic techniques.

Images from Shutterstock

Follow us on Telegram.
Advertisement

Published at Wed, 09 May 2018 20:00:40 +0000

Exchanges

Previous Article

Tech Investor: Bitcoin Could be Betamax to Another Crypto’s VHS

Next Article

Bloomberg Partners Novogratz’s Galaxy Digital Capital To Release Crypto Benchmark Index

You might be interested in …

The Next Doctor You Consult Could Be a Robot: Healthcare Meets AI and the Blockchain

The Next Doctor You Consult Could Be a Robot

Startup company doc.ai has been working with university researchers to create a platform on the blockchain where patients can discuss their medical data with an advanced artificial intelligence “doctor.”

On August 24, doc.ai announced that their advanced natural language processing technology platform, based on the blockchain, would timestamp datasets and decentralize artificial intelligence. The startup stated that the platform was “envisioned and built” by researchers from Stanford and Cambridge Universities.

The objective of the company is to help healthcare companies improve patient care and  experience through an advanced natural dialogue system which will be able to generate insights from combined medical data.

According to the World Health Organization, there is a shortage of seven million healthcare professionals globally, and that number is on the rise. There is increasing pressure on doctors who are faced with meeting the challenging needs of the population and keeping up with the latest developments in healthcare and medicine. Furthermore, the training of healthcare professionals takes years of education and experience. With the help of AI, doc.ai aims to address such challenges while improving the patient care and providing a better healthcare experience.

“We are making it possible for lab tests to converse directly with patients by leveraging advanced artificial intelligence, medical data forensics, and the decentralized blockchain. We envision extensive possibilities for the use of this technology by doctors, patients, and medical institutions,” Walter De Brouwer, founder and chief executive officer of doc.ai, said in a statement.

Deloitte Life Sciences and Healthcare is working with doc.ai to test the company’s Robo-hematology solution, which was developed recently at the Deloitte University in Dallas, Texas.

“doc.ai’s AI-based doctors provide answers to health questions using an AI-powered platform. Platforms like these open new possibilities for patients and medical organizations by providing more personalized, intelligent healthcare. We are excited to collaborate with doc.ai and to be at the forefront of this technology,” said Rajeev Ronanki, Principal of Life Sciences and Health Care at Deloitte Consulting LLP.

The platform operates as a Software as a Service (SaaS), providing service to medical companies, which will allow their patients to have personalized AI-powered conversations about their health around the clock. The conversations are personalized, based on the patient’s health data via a mobile app. The company expects to roll out three natural language processing modules — Robo-genomics, Robo-hematology and Robo-anatomics — for their clients.

Patients can ask the AI questions related to their health, such as “What should be my optimal Ferritin value based on my iron storage deficiency?” or “How can I decrease my cholesterol in the next 3 weeks?” or “Why was my glucose level over 100 and a week later it is at 93?”

According to doc.ai, the artificial intelligence will be able to provide answers for the patients with additional context for each answer. Furthermore, patients can communicate with the “AI-powered robo-doctor” to “achieve better health outcomes” from consultations with the patient’s physician.

The post The Next Doctor You Consult Could Be a Robot: Healthcare Meets AI and the Blockchain appeared first on Bitcoin Magazine.